Research Institute of Molecular Pathology

Research Institute of Molecular Pathology
Name	Research Institute of Molecular Pathology
Established	1988
Location	Vienna, Austria
Type	Basic research institute
Director	Magnus Mannsperger
Staff	~250

Research Institute of Molecular Pathology is an independent biomedical research institute located in Vienna, Austria, affiliated historically with the pharmaceutical company Novartis and the philanthropic organization Ernst Guttmann Stiftung. The institute has engaged with the scientific communities of Max Perutz-era Medical University of Vienna, Austrian Academy of Sciences, and international consortia including partners in European Molecular Biology Laboratory, Wellcome Trust, and Howard Hughes Medical Institute. Its work sits at the nexus of molecular biology, structural biology, and translational science, interacting with institutions such as University of Vienna, ETH Zurich, Karolinska Institutet, and Cold Spring Harbor Laboratory.

History

The institute was founded in 1988 during a period of expansion of biomedical research in Europe, contemporaneous with institutions like European Molecular Biology Organization, EMBL infrastructure projects, and the founding of Institut Pasteur satellite collaborations. Early directors and founding scientists had ties to laboratories of Max Perutz, Walter Gilbert, and James Watson-era networks, and the institute later hosted researchers who trained at Harvard University, Massachusetts Institute of Technology, University of Cambridge, and Stanford University. Over time the institute developed collaborations with industry partners including Novartis, Roche, and Pfizer, and it participated in European Union Framework Programme projects alongside groups from Karlsruhe Institute of Technology, Heidelberg University, and University College London. Significant milestones include expansion of laboratory space in the 1990s, establishment of core facilities parallel to those at European Bioinformatics Institute and Max Planck Institute for Biochemistry, and participation in drug discovery consortia that included AstraZeneca.

Mission and Research Focus

The institute’s mission emphasizes fundamental investigation of molecular mechanisms underlying human disease, aligning with priorities set by entities like World Health Organization, European Commission, and funding bodies such as European Research Council and Gordon and Betty Moore Foundation. Research areas include structural biology comparable to work at MRC Laboratory of Molecular Biology, cell signaling networks paralleling studies from Cold Spring Harbor Laboratory, and genomics approaches akin to projects at Broad Institute. Investigations address protein folding and misfolding related to studies by Christian Anfinsen and Stanley Prusiner, signaling cascades in the tradition of Edwin Krebs, and chromatin biology connected to findings from EMBO-affiliated groups. The institute fosters translational links with clinical centers such as Vienna General Hospital and international translational hubs like Mayo Clinic.

Organization and Governance

Governance structures reflect models used by Max Planck Society and Howard Hughes Medical Institute, including a scientific advisory board composed of members from Harvard Medical School, ETH Zurich, Imperial College London, and University of California, San Francisco. The board provides oversight similar to that at Salk Institute and Francis Crick Institute. Administrative functions coordinate with regional bodies such as the City of Vienna and national agencies like the Austrian Federal Ministry of Education, Science and Research. Executive leadership has historically included scientists with training at Princeton University, Yale University, and University of Oxford.

Facilities and Resources

Core facilities host technologies paralleling those at European Molecular Biology Laboratory, including cryo-electron microscopy comparable to instruments used at Max Planck Institute for Biophysical Chemistry, X-ray crystallography facilities akin to Diamond Light Source users, next-generation sequencing platforms similar to Wellcome Sanger Institute, and high-content screening suites like those at Broad Institute. The institute maintains bioinformatics resources that interoperate with databases such as UniProt, Protein Data Bank, and Ensembl. Collaborative laboratory space supports joint projects with centers like Research Center for Molecular Medicine (CeMM) and Institute of Molecular Biotechnology (IMBA).

Notable Research and Contributions

Scientists affiliated with the institute have contributed to advances in signal transduction research in the lineage of Tony Hunter, structural insights echoing work by Ada Yonath, and methodologies for chemical biology reminiscent of Stuart Schreiber and Ben Cravatt. Publications have intersected with topics investigated at Nature, Science, and Cell, and the institute has participated in multi-institutional studies with teams from Broad Institute, European Bioinformatics Institute, and Max Planck Institute for Molecular Cell Biology and Genetics. Noteworthy contributions include identification of regulatory protein interactions that informed drug-target validation efforts seen in collaborations with Novartis and Roche and methodological innovations in imaging and proteomics paralleling work at EMBL Heidelberg.

Funding and Partnerships

Funding derives from a mix of private philanthropy similar to gifts from Gordon and Betty Moore Foundation and corporate support historically reminiscent of arrangements with Novartis, alongside competitive grants from European Research Council, Horizon 2020, and national programs administered by the Austrian Science Fund (FWF). Strategic partnerships have included collaborations with pharmaceutical companies such as Novartis and Pfizer, academic consortia including University of Vienna and Medical University of Vienna, and international networks like EMBO and European Research Infrastructure Consortia.

Education, Training, and Outreach

The institute operates doctoral and postdoctoral training programs partnering with universities like University of Vienna, Medical University of Vienna, and Technical University of Vienna, following training models used at European Molecular Biology Laboratory and Max Planck Institutes. Outreach activities include seminars and public lectures in collaboration with institutions such as Austrian Science Fund events, participation in outreach festivals alongside Vienna BioCenter, and exchange programs with Cold Spring Harbor Laboratory and Karolinska Institutet. The institute has hosted visiting scholars from Harvard University, Stanford University, ETH Zurich, and University College London.

Category:Research institutes in Austria